Title for MeetingAbstracts
Alphabetical listing of titles
Autoantibodies against collagen in AIDS; correlation with risk factors and disease progression.
Autoantibodies in HIV-related peripheral neuropathy.
Autoantibodies to CD43 (leukosialin) in HIV-1-infected individuals.
Autoantibodies to nucleosomes in HIV-infection.
Autocrine and paracrine growth stimulation of Kaposi's sarcoma-derived cell cultures.
Autocrine expression of tumor necrosis factor alpha (TNF-alpha) and NF-kB play a central role in the ability of HIV to replicate in U937 promonocytic cells.
Autofinancial medical care clinical unit for people living with HIV/AIDS.
Autogenic-Feedback Training as a preventive method for Space Adaptation Syndrome on Space-Lab 3.
Autoimmune hemolytic anemia in SIVsmm infected macaca mulatta.
Autoimmune hypothyroidism under HAART: possible interactions between indinavir (IDV) and levothyroxine.
Autoimmunity against neutrophils and thrombocytes in different stages of HIV-infection.
Autologous and recombinant HIV-1 core particles produced in different eucaryotic expression systems as a vaccine candidate.
AUTOLOGOUS BLOOD VERSUS ALLOGENIC BLOOD: WHEN THE BEST IS THE ENEMY OF THE GOOD.
Autologous Fat Transfer for Treating Facial Wasting in HIV Body Fat Redistribution Syndrome.
Autologous fat transfer for treating facial wasting in HIV body fat redistribution syndrome.
Autologous Hematopoietic Stem Cell Transplantation for AIDS-related Lymphoma.
AUTOLOGOUS NEUTRALIZATION AND NEUTRALIZATION ESCAPE IN HIV-2 INFECTION.
Autologous neutralization and neutralization escape in HIV-2 infection.
Autologous neutralizing antibodies (ANA) and viral load in HIV-2 infected individuals.
Autologous Neutralizing Antibody (ANAB) to Concurrent and CD4 T-Cell-Recovered Virus in HIV Infected Children on HAART.
Autologous Neutralizing Antibody Responses Drive the Evolution of HIV-1 env in Recently Infected Patients.
Autologus isolate neutralizing antibodies in plasma from HIV-1 infected patients on highly active antiretroviral therapy.
Automated cervical cancer screening technologies for slide preparation and assisted screening: analysis and comparison.
Automated chemiluminescence assay for the detection of antibody to human immunodeficiency virus type-1 (HIV) in serum and whole blood.
Automated Detection of HPV Molecular Markers by In Situ Hybridization for Cervical Cancer Diagnostics.
Automated eligibility evaluation for HIV clinical trials.
Automated evaluation of treatment outcomes: update on the continual improvement and quality management of health care.
Automated microbiology system for Space Station Freedom.
Automated MIRU Typing of Mycobacterium tuberculosis by PCR and WAVE Nucleic Acid Fragment Analysis System.
Automated nucleic acid purification for viral load and sequencing using the NucliSens(TM) extractor.